Skip to main navigation Skip to search Skip to main content

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Application and Interpretation of the Residual Tumor Classification for Lung Cancer—Results from an International Survey Among Pathologists and Thoracic Surgeons

  • Hans Hoffmann
  • , Andrew G. Nicholson
  • , Frank C. Detterbeck
  • , Ming S. Tsao
  • , Marcin Ostrowski
  • , Ramón Rami-Porta
  • , Alain Borczuk
  • , Mirella Marino
  • , William D. Travis
  • , Paul E. Van Schil
  • , John Edwards
  • National Heart and Lung Institute
  • Yale University Medical School
  • Princess Margaret Hospital
  • Medical Unversity of Gdansk
  • Hospital Universitari de Bellvitge
  • Weill Cornell Medicine
  • Experimental Chemotherapy Laboratory
  • Weill Cornell Medical College
  • Antwerp University Hospital
  • Sheffield Teaching Hospitals NHS Foundation Trust

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Objectives: The study aimed to assess the opinion of pathologists and thoracic surgeons of the International Association for the Study of Lung Cancer regarding the application and interpretation of the residual tumor (R) classification for lung cancer. Methods: On the basis of their membership profiles, a total of 623 pathologists and thoracic surgeons were identified and contacted by email with a cover letter and a link to an online survey. The questionnaire consisted of 12 questions about various aspects of the application and interpretation of the R classification for lung cancer. The response rate (to at least one question) was 72% (144 pathologists and 303 surgeons). Results: The frequency of use of the R classification varies by geographic region. Although R status is regularly reported in Europe and Asia, 70% of pathologists in the United States and Canada never include R status in reports. Similar variations exist about who assigns the R category for the resection—in Europe and the United Kingdom, it is mainly the pathologist, whereas in China, Japan and the United States, it is the surgeon. There are some good agreements about margins examined and how to manage staple lines. The category “uncertain resection” has not been practically implemented in most of the world, except at some centers in Japan and the United Kingdom. Conclusion: This survey shows that surgical resection margins are part of routine reporting in most institutions; but the assignment of an R category is not always part of the pathology report, with considerable variation between countries. Despite the International Association for the Study of Lung Cancer proposals, the application of the uncertain resection category has not been taken up by most institutions, and further evidence is needed.

Original languageEnglish
Pages (from-to)597-613
Number of pages17
JournalJournal of Thoracic Oncology
Volume20
Issue number5
DOIs
StatePublished - May 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Complete resection
  • Lung cancer
  • Residual disease
  • Surgery

Fingerprint

Dive into the research topics of 'The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Application and Interpretation of the Residual Tumor Classification for Lung Cancer—Results from an International Survey Among Pathologists and Thoracic Surgeons'. Together they form a unique fingerprint.

Cite this